Tubulin polymerization assay using >99% pure tubulin, OD based - Porcine (BK006P)

Tubulin polymerization HTS assay using >99% pure tubulin, OD based - Porcine (BK006P)

Product Uses Include

  1. Screening compounds for effects on tubulin polymerization activity.
  2. Screening proteins for effects on tubulin polymerization activity.
  3. Determining that tubulin alone (not MAPs) is the target for compounds that affect microtubule polymerization.
  4. Teaching aid for undergraduate/graduate class in pharmacology.

This assay is based on an adaptation of the original method of Shelanski et al. and Lee et al. (1,2), which demonstrated that light is scattered by microtubules to an extent that is proportional to the concentration of microtubule polymer. The resulting polymerization curve is representative of the three phases of microtubule polymerization, namely nucleation, growth and steady state equilibrium. See the About Tubulin page for more information. The assay is optimized for a 96-well format for low CVs and efficient sample handling.

This kit contains the porcine neuronal tubulin of the highest available purity (>99% pure, Cat. # T240). The same type of assay is also available with HTS tubulin (Cat. # BK004P) and can serve as an economical, but slightly less sensitive alternative to BK006P. HTS tubulin (Cat. # HTS03) is >97% pure. Cytoskeleton, Inc. also provides a fluorescence based tubulin polymerization assay in miniaturized format (Cat. # BK011P) making it ideal for high throughput screening.

If you are interested in using either of these tubulin polymerization assays in a high throughput setting, please contact our technical service department for advice and bulk quotes.

Kit contents
This kit contains enough materials for 24 assays (BK006P). The following reagents are included:

  1. Tubulin, >99% pure, lyophilized (Cat. # T240)
  2. GTP solution (Cat. # BST06)
  3. General tubulin buffer (PEM, Cat. # BST01)
  4. Tubulin glycerol buffer (Cat. # BST05)
  5. Paclitaxel positive control (Cat. # TXD01)
  6. DMSO for paclitaxel.
  7. Half area 96-well plate for polymerization reactions
  8. Manual with detailed protocols and extensive troubleshooting guide.

Equipment needed

  1. 96-well plate spectrophotometer with filters to read optical density at 340 nm.
  2. Multi-channel pipette for rapid pipetting of tubulin

Example results
The BK006P kit was used to study the effects of Paclitaxel, a polymerization enhancer and Nocodazole, a polymerization inhibitor on tubulin polymerization (Fig. 1)


 Figure 1. Tubulin polymerization curves from kit BK006P. The figure shows a standard polymerization curve (Control curve) containing a 100 µl volume of 3 mg/ml tubulin in 80 mM PIPES pH 7.0, 0.5 mM EGTA, 2 mM MgCl2, 1 mM GTP and 10% glycerol. Polymerization was started by incubation at 37°C and followed by absorption readings at 340 nm. Under these conditions, polymerization Vmax is enhanced 4 fold in the presence of 10 µM paclitaxel and reduced 5.5 fold in the presence of 10 µM nocodazole.


  1. Shelanski, M. L., Gaskin, F. and Cantor, C. R. (1973). Microtubule assembly in the absence of added nucleotides. Proc. Natl. Acad. Sci. U.S.A. 70, 765-768.
  2. Lee, J. C. and Timasheff, S. N. (1977). In vitro reconstitution of calf brain microtubules: effects of solution variable. Biochemistry, 16, 1754-1762.

For product Datasheets and MSDSs please click on the PDF links below.   For additional information, click on the FAQs tab above or contact our Technical Support department at tservice@cytoskeleton.com


  •   For our Tubulin Polymerization (Absorbance) Excel Template please download here.
  •   For our IC50 from Vmax Polymerization Excel Template please download here.
AuthorTitleJournalYearArticle Link
Yang, Dong Lin et al.Pyrrolyldihydropyrazino[1,2-a]indoletrione Analogue Microtubule Inhibitor Induces Cell-Cycle Arrest and Apoptosis in Colorectal Cancer CellsMolecules2023ISSN 1420-3049
Zoroddu, Stefano et al.RNAseq Analysis of Novel 1,3,4-Oxadiazole Chalcogen Analogues Reveals Anti-Tubulin Properties on Cancer Cell LinesInternational Journal of Molecular Sciences2023ISSN 1422-0067
Song, In ho et al.Not all benzimidazole derivatives are microtubule destabilizing agentsBiomedicine & Pharmacotherapy2023
Tu, Huang Ju et al.Urolithin A exhibits a neuroprotective effect against Alzheimer’s disease by inhibiting DYRK1A activityJournal of Food and Drug Analysis2023ISSN 2224-6614
De Abreu, Isadora Rocha et al.A molecular analysis of substituted phenylethylamines as potential microtubule targeting agents through in silico methods and in vitro microtubule-polymerization activityScientific Reports 2023 13:12023ISSN 2045--2322
Sharma, Sachin et al.Flavone-based dual PARP-Tubulin inhibitor manifesting efficacy against endometrial cancerJournal of Enzyme Inhibition and Medicinal Chemistry2023ISSN 1475-6374
Ana, Gloria et al.Synthesis and biological evaluation of 1‐(Diarylmethyl)‐1h‐1,2,4‐triazoles and 1‐(diarylmethyl)‐1h‐imidazoles as a novel class of anti‐mitotic agent for activity in breast cancerPharmaceuticals2021ISSN 1424-8247
Khayyat, Ahdab N. et al.Design, synthesis, and antipoliferative activities of novel substituted imidazole-thione linked benzotriazole derivativesMolecules2021ISSN 1420-3049
Malebari, Azizah M. et al.Synthesis and antiproliferative evaluation of 3‐chloroazetidin‐2‐ones with antimitotic activity: Heterocyclic bridged analogues of combretastatin a‐4Pharmaceuticals2021ISSN 1424-8247
Ibrahim, Tarek S. et al.Discovery of novel quinoline-based analogues of combretastatin A-4 as tubulin polymerisation inhibitors with apoptosis inducing activity and potent anticancer effectJournal of Enzyme Inhibition and Medicinal Chemistry2021ISSN 1475-6374
Malebari, Azizah M. et al.β-Lactams with antiproliferative and antiapoptotic activity in breast and chemoresistant colon cancer cellsEuropean Journal of Medicinal Chemistry2020ISSN 1768-3254
Ibrahim, T S et al.Potent quinoline-containing combretastatin a-4 analogues: design, synthesis, antiproliferative, and anti-tubulin activityPharmaceuticals2020Article Link
Wang, Shu et al.3-Vinylazetidin-2-Ones: Synthesis, antiproliferative and tubulin destabilizing activity in MCF-7 and MDA-MB-231 Breast Cancer CellsPharmaceuticals2019ISSN 1424-8247
Schneidewind, Tabea et al.The Pseudo Natural Product Myokinasib Is a Myosin Light Chain Kinase 1 Inhibitor with Unprecedented ChemotypeCell Chemical Biology2019ISSN 2451-9448
Malebari, Azizah M. et al.β-Lactam analogues of combretastatin A-4 prevent metabolic inactivation by glucuronidation in chemoresistant HT-29 colon cancer cellsEuropean Journal of Medicinal Chemistry2017ISSN 1768-3254
Majellaro, Maria et al.Investigating Structural Requirements for the Antiproliferative Activity of Biphenyl NicotinamidesChemMedChem2017ISSN 1860-7187
Ayoub, Ahmed Taha et al.Antitumor Activity of Lankacidin Group Antibiotics Is Due to Microtubule Stabilization via a Paclitaxel-like MechanismJournal of Medicinal Chemistry2016ISSN 1520-4804
Chan, Eddie et al.The acetylenic tricyclic bis(cyano enone), TBE-31, targets microtubule dynamics and cell polarity in migrating cellsBiochimica et Biophysica Acta - Molecular Cell Research2016ISSN 1879-2596
Tsai, An Chi et al.In vitro and in vivo anti-tumour effects of MPT0B014, a novel derivative aroylquinoline, and in combination with erlotinib in human non-small-cell lung cancer cellsBritish Journal of Pharmacology2014ISSN 0007-1188
Tsai, A. C. et al.Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinibCell Death & Disease 2014ISSN 2041--4889
Jackson, Steven J.T. et al.Curcumin binds tubulin, induces mitotic catastrophe, and impedes normal endothelial cell proliferationFood and Chemical Toxicology2013ISSN 0278-6915
Hartley, R. M. et al.Polygamain, a New Microtubule Depolymerizing Agent That Occupies a Unique Pharmacophore in the Colchicine SiteMolecular Pharmacology2012ISSN 0026-895X
Chen, Chun Han et al.Protopine, a novel microtubule-stabilizing agent, causes mitotic arrest and apoptotic cell death in human hormone-refractory prostate cancer cell lines2012PMID 22033245
Brachmann, Saskia M. et al.Characterization of the mechanism of action of the pan class i PI3K inhibitor NVP-BKM120 across a broad range of concentrationsMolecular Cancer Therapeutics2012ISSN 1535-7163
Carletti, B. et al.Effect of protein glutathionylation on neuronal cytoskeleton: a potential link to neurodegenerationNeuroscience2011ISSN 1873--7544
Risinger, A. L. et al.ELR510444, a novel microtubule disruptor with multiple mechanisms of actionThe Journal of pharmacology and experimental therapeutics2011ISSN 1521--0103
Faridi, Uzma et al.Proteomics indicates modulation of tubulin polymerization by L-menthol inhibiting human epithelial colorectal adenocarcinoma cell proliferation2011ISSN 1615--9861
Chang, Chia Hao et al.Mycotoxin citrinin induced cell cycle G2/M arrest and numerical chromosomal aberration associated with disruption of microtubule formation in human cellsToxicological sciences : an official journal of the Society of Toxicology2011ISSN 1096--0929
O'Boyle, Niamh M. et al.Synthesis, evaluation and structural studies of antiproliferative tubulin-targeting azetidin-2-onesBioorganic and Medicinal Chemistry2011ISSN 0968-0896
Geng, Feng et al.Allyl isothiocyanate arrests cancer cells in mitosis, and mitotic arrest in turn leads to apoptosis via Bcl-2 protein phosphorylationJournal of Biological Chemistry2011ISSN 0021-9258
O'Boyle, Niamh M. et al.Synthesis and evaluation of azetidinone analogues of combretastatin A-4 as tubulin targeting agentsJournal of Medicinal Chemistry2010ISSN 0022-2623
Yang, Jai Sing et al.MJ-29 inhibits tubulin polymerization, induces mitotic arrest, and triggers apoptosis via cyclin-dependent kinase 1-mediated Bcl-2 phosphorylation in human leukemia U937 cellsJournal of Pharmacology and Experimental Therapeutics2010ISSN 0022-3565
Tovar, Christian et al.Small-molecule inducer of cancer cell polyploidy promotes apoptosis or senescence: Implications for therapyCell Cycle2010ISSN 1551-4005
Kushkuley, Jacob et al.Neurofilament cross-bridging competes with kinesin-dependent association of neurofilaments with microtubulesJournal of cell science2009ISSN 1477--9137
Kien, Voon Kong et al.Osmium carbonyl clusters containing labile ligands hyperstabilize microtubulesChemical Research in Toxicology2009ISSN 0893-228X
Huang, Yao Ting et al.CIL-102 interacts with microtubule polymerization and causes mitotic arrest following apoptosis in the human prostate cancer PC-3 cell lineThe Journal of biological chemistry2005ISSN 0021--9258
Jackson, Steven J.T. et al.Sulforaphane inhibits human MCF-7 mammary cancer cell mitotic progression and tubulin polymerizationJournal of Nutrition2004ISSN 0022-3166
Jackson, Steven J.T. et al.Sulforaphane: A naturally occuring mammary carcinoma mitotic inhibitor, which disrupts tubulin polymerizationCarcinogenesis2004ISSN 0143-3334


Question 1: What is the difference between this kit and BK004P?

Answer 1:  Both the BK004P and BK006P are tubulin polymerization kits that are absorbance-based rather than fluorescence-based.  The only difference between the two absorbance-based kits is that BK004P uses 97% pure tubulin (remaining 3% are MAPs) while BK006P uses >99% pure tubulin.  This is an important difference because the presence of MAPs means that tubulin polymerization can be examined in the absence of enhancers such as glycerol or taxol with as little as 3 or 4 mg/ml tubulin using the BK004P kit.  In this case MAPs act as polymerization enhancers.  With BK006P, an enhancer such as glycerol or taxol must be used to drive tubulin polymerization with concentrations <5 mg/ml tubulin.  Using tubulin at 5 mg/ml or higher allows for the omission of glycerol or taxol.  In some cases, glycerol can interfere with the binding of tubulin accessory proteins or compounds.  Assay conditions can easily be altered to test for glycerol interference.


Question 2: Which kit is best for screening a compound/reagent/drµg for its effects on tubulin polymerization?

Answer 2:  All 3 tubulin polymerization kits (2 absorbance-based kits, BK004P and BK006P; 1 fluorescence-based kit, BK011P) are well-suited for screening of potential tubulin polymerization enhancers and inhibitors.  Each kit has its own pros and cons.  For initial compound/drµg screening, we recommend the absorbance-based tubulin polymerization assay BK004P.  This kit uses 97% pure tubulin (remaining 3% are MAPs) while BK006P and BK011P use >99% pure tubulin.  This is an important difference because the presence of MAPs means that tubulin polymerization can be examined in the absence of enhancers or inhibitors with as little as 3 or 4 mg/ml tubulin using the BK004P kit.  To study enhancers, we recommend using 3 mg/ml tubulin, whereas 4 mg/ml tubulin is recommended for inhibitors.  In the case of BK004P, MAPs act as polymerization enhancers.  With BK006P and BK011P, an enhancer such as glycerol or taxol must be used to drive tubulin polymerization with concentrations <5 mg/ml tubulin.  Using tubulin at 5 mg/ml or higher allows for the omission of glycerol or taxol, but requires additional tubulin.  In some cases, glycerol can interfere with the binding of tubulin accessory proteins or compounds/reagents/drµgs.  However, since BK011P is fluorescence-based, there is increased sensitivity that allows the researcher to use 1/3 as much tubulin with greater sensitivity.  Thus, the kit provides 96 assays versus the 30 assays of BK004P or BK006P, thus BK011P is the most economical when requiring >30 assays for the project.


Question 3: How does porcine tubulin compare to bovine tubulin?

Answer 3: Click here for an in-depth comparison of porcine and bovine tubulin.

If you have any questions concerning this product, please contact our Technical Service department at tservice@cytoskeleton.com